HALO   $49.0  7.17% Market Closed After Close 49.6099 1.24%

Halozyme Therapeutics Inc
Total Cash 666.31M
totalCashPerShare 5.237
EBITDA 553.00M
Total Debt 1.53B
quickRatio 8.749
currentRatio 10.357
Total Revenue 947.36M
debtToEquity 339.054
Revenue/Share 7.431
ROA 0.14867
ROE 1.11832
grossProfits
freeCashflow 339.29M
operatingCashflow 402.95M
earningsGrowth 0.72
revenueGrowth 0.343
grossMargins 0.73653
ebitdaMargins 0.58373
operatingMargins 0.56259
profitMargins 0.41428003
enterpriseValue 8.58B
forwardPE 12.710692
floatShares 125.89M
sharesOutstanding 127.23M
sharesShort 10.42M
sharesShortPriorMonth 9.64M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.01%
Short Ratio help_outline 6.59%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue 3.559
Price To Book help_outline 17.04
earningsQuarterlyGrowth 0.67
netIncomeToCommon 392.47M
trailingEps 3.12%
forwardEps 4.77%
enterpriseToEbitda 15.52
lastDividendValue
lastDividendDate
currentQuarterEstimate 1.19 4Q 2024
institutionsCount 656
lastUpdated Nov. 7, 2024, 9:27 a.m.